NO992339L - Farmasöytiske formuleringer - Google Patents

Farmasöytiske formuleringer

Info

Publication number
NO992339L
NO992339L NO992339A NO992339A NO992339L NO 992339 L NO992339 L NO 992339L NO 992339 A NO992339 A NO 992339A NO 992339 A NO992339 A NO 992339A NO 992339 L NO992339 L NO 992339L
Authority
NO
Norway
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
NO992339A
Other languages
English (en)
Other versions
NO992339D0 (no
Inventor
Cristi Bell-Huff
Thomas Francis Dolan
Angela Carol Gatlin Hausberger
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO992339D0 publication Critical patent/NO992339D0/no
Publication of NO992339L publication Critical patent/NO992339L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
NO992339A 1998-05-15 1999-05-14 Farmasöytiske formuleringer NO992339L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8564698P 1998-05-15 1998-05-15

Publications (2)

Publication Number Publication Date
NO992339D0 NO992339D0 (no) 1999-05-14
NO992339L true NO992339L (no) 1999-11-16

Family

ID=22193027

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992339A NO992339L (no) 1998-05-15 1999-05-14 Farmasöytiske formuleringer

Country Status (32)

Country Link
US (1) US20020002172A1 (no)
EP (1) EP0960621A3 (no)
JP (1) JPH11349483A (no)
KR (1) KR19990088249A (no)
CN (1) CN1251758A (no)
AP (1) AP9901534A0 (no)
AR (1) AR016481A1 (no)
AU (1) AU753478B2 (no)
BG (1) BG103396A (no)
BR (1) BR9902086A (no)
CA (1) CA2272042A1 (no)
CO (1) CO5060503A1 (no)
DZ (1) DZ2786A1 (no)
EA (1) EA002830B1 (no)
GT (1) GT199900061A (no)
HN (1) HN1999000066A (no)
HR (1) HRP990144A2 (no)
HU (1) HUP9901606A2 (no)
ID (1) ID23299A (no)
IS (1) IS5046A (no)
MA (1) MA26629A1 (no)
NO (1) NO992339L (no)
NZ (1) NZ335772A (no)
OA (1) OA11040A (no)
PA (1) PA8472901A1 (no)
PE (1) PE20000546A1 (no)
PL (1) PL333118A1 (no)
SG (1) SG79255A1 (no)
SK (1) SK61599A3 (no)
TR (1) TR199901077A2 (no)
YU (1) YU21999A (no)
ZA (1) ZA993338B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2346350C (en) * 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
CA2362918A1 (en) * 1999-03-08 2000-09-14 Elizabeth Stoner Methods and compositions for treating erectile dysfunction
AU3744800A (en) * 1999-03-16 2000-10-04 Pentech Pharmaceuticals, Inc. Controlled release of sildenafil delivered by sublingual or buccal administration
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
US7501409B2 (en) 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (no) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
JPWO2003028706A1 (ja) * 2001-09-28 2005-01-13 株式会社三和化学研究所 有核型速溶崩壊性成型品
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
WO2004073729A1 (ja) * 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
US7278982B2 (en) 2003-03-27 2007-10-09 Bioactis Limited Powder medicine applicator for nasal cavity
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US8673360B2 (en) * 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP1898879A1 (en) * 2005-06-23 2008-03-19 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
BRPI0616633A2 (pt) * 2005-09-29 2011-06-28 Bayer Healthcare Ag inibidores de pde e combinações dos mesmos para o tratamento de transtornos urológicos
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
SG178775A1 (en) * 2007-02-12 2012-03-29 Dmi Biosciences Inc Reducing side effects of tramadol
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
FR2932682B1 (fr) * 2008-06-23 2013-07-12 Bionetwork Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
CA2753685C (en) * 2009-03-09 2017-09-12 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
GB2472327B (en) * 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
EP2338474A1 (de) 2009-12-23 2011-06-29 Ratiopharm GmbH Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
AU2012214939B2 (en) * 2011-02-11 2016-11-17 Ctc Bio, Inc. Sildenafil-free base-containing film preparation and method for producing same
KR101418406B1 (ko) * 2011-08-24 2014-07-10 한미약품 주식회사 실데나필 유리 염기를 포함하는 구강 붕해정
MX366768B (es) * 2011-12-08 2019-07-17 Laboratorios Liomont S A De C V Tableta orodispersable de sildenafil y metodo para preparar la misma.
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN114246835A (zh) * 2022-01-05 2022-03-29 河北龙海药业有限公司 一种枸橼酸西地那非口腔崩解片的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE19532142A1 (de) * 1995-08-31 1997-03-06 Siemens Ag Verfahren und Vorrichtung zur Regelung eines vierdimensionalen Vektors einer Strecke mittels eines wertediskreten Stellgliedes mit begrenzter Schaltfrequenz
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
EP0992240A4 (en) * 1997-05-29 2003-04-16 Mochida Pharm Co Ltd THERAPEUTIC AGENT FOR TREATING ANERECTION
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
AU3744800A (en) * 1999-03-16 2000-10-04 Pentech Pharmaceuticals, Inc. Controlled release of sildenafil delivered by sublingual or buccal administration

Also Published As

Publication number Publication date
HU9901606D0 (en) 1999-07-28
EP0960621A3 (en) 2000-01-05
EA199900373A3 (ru) 2000-08-28
AU2812699A (en) 1999-11-25
US20020002172A1 (en) 2002-01-03
ID23299A (id) 2000-04-05
EA002830B1 (ru) 2002-10-31
AU753478B2 (en) 2002-10-17
IS5046A (is) 1999-11-16
OA11040A (en) 2003-01-01
EP0960621A2 (en) 1999-12-01
GT199900061A (es) 2000-10-14
PE20000546A1 (es) 2000-07-07
EA199900373A2 (ru) 1999-12-29
NZ335772A (en) 2000-12-22
YU21999A (sh) 2002-03-18
AR016481A1 (es) 2001-07-04
CA2272042A1 (en) 1999-11-15
BR9902086A (pt) 2000-05-02
CO5060503A1 (es) 2001-07-30
AP9901534A0 (en) 1999-06-30
JPH11349483A (ja) 1999-12-21
SG79255A1 (en) 2001-03-20
MA26629A1 (fr) 2004-12-20
PL333118A1 (en) 1999-11-22
SK61599A3 (en) 2000-12-11
TR199901077A3 (tr) 1999-12-21
HN1999000066A (es) 1999-09-29
BG103396A (bg) 2000-01-31
HRP990144A2 (en) 2000-02-29
DZ2786A1 (fr) 2003-12-01
NO992339D0 (no) 1999-05-14
TR199901077A2 (en) 1999-12-21
KR19990088249A (ko) 1999-12-27
CN1251758A (zh) 2000-05-03
ZA993338B (en) 2000-11-14
PA8472901A1 (es) 2000-09-29
HUP9901606A2 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
NO992339L (no) Farmasöytiske formuleringer
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
ID27415A (id) Komposisi farmaseutik
NO20004240D0 (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
NO20005913L (no) Legemiddelsammensetning
NO20012915D0 (no) Ny farmasöytisk formulering
ID24654A (id) Formulasi farmasi omeprazola
PT1130966E (pt) Formulacoes antiparasitarias
MA24473A1 (fr) Formulations
ID29262A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
ID27201A (id) Komposisi farmasi
IS6398A (is) Lyfjablöndur
EE05375B1 (et) LevosimendaniÁfarmatseutilineÁlahus
ID16781A (id) Formulasi-formulasi farmasi
IS2515B (is) Lyfjasamsetningar
ID30032A (id) Formulasi farmasi
EE200000330A (et) Farmatseutilised kompositsioonid
EE04217B1 (et) Farmatseutilised kompositsioonid
NO994436L (no) Farmasöytiske sammensetninger
SE9803952D0 (sv) Pharmaceutical formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application